Pharmacy benefit costs continue to rise, with specialty drugs, GLP-1 therapies, and emerging biosimilars reshaping employer health strategies. In this episode of NEBGH Voices, Kim Thiboldeaux sits down with Ryan Czado, Chief Pharmacy Officer at RazorMetrics, to explore the most important pharmacy and specialty drug trends benefits leaders should be tracking.
The conversation examines growing investment in point solutions, the evolving pharmacy ecosystem, employer transparency and privacy considerations, and the increasing focus on utilization management. Ryan also shares insights into cardiometabolic care, expanded GLP-1 indications, biosimilars, and the ongoing challenge of balancing affordability with clinical outcomes. As employers plan for 2026 and beyond, this episode offers practical perspectives on building a thoughtful, data-driven pharmacy strategy that aligns financial stewardship with member health.
This episode of NEBGH Voices is sponsored by RazorMetrics.
NEBGH Voices is produced by: Deren Abrams, Adria Subbiondo, and Christian Waugh